Themis Bioscience

Prophylactic vaccines for infectious diseases

placeVienna, Vienna, Austria calendar_todayFounded 2009 groups40 employees language themisbio.com

Investor mix

16 investors on record; lead investors include Global Health Investment Fund, Omnes Capital, Ventech, Wellington Partners Venture Capital; 2 have since exited.

Investor typeCountShare
Venture capital638%
Private equity319%
Accelerator & incubator16%
Bank & private debt16%
Other / undisclosed531%
Coming soon